The costs of developing apps for market access are fragmented and spread out across country affiliates. As a result, it’s hard to see how it adds up, and often no one appreciates how much is being spent.
When you factor in the expense of localizing and maintaining apps, the overall cost can be surprisingly high.
Why are my costs so high?
The ‘iPad revolution’ has caused a surge in the number of digital content providers, developing a range of mobile tools for the life sciences industry. HEOR consultancies now frequently include the option to purchase customer engagement apps for use in market access discussions with payers and providers.
One of the results has been an explosion of digital content across businesses. Pharma and medical device companies often have multiple versions of apps for multiple products in different country markets; all of which need to be updated (by the local vendor) and supported (by IT teams) at considerable expense and difficulty.
How is BaseCase different?
One of the key advantages of our software is that it provides a way for life sciences companies to contain costs, while expanding the development of mobile apps for customer engagement across the business.
BaseCase Interactive removes programmers and app vendors from the equation. Your market access and health economics teams can develop and update apps for engagement with payers and providers in-house, just as they would an Excel spreadsheet or a PowerPoint presentation.
It also enables you to stop reinventing the wheel in every country. Our software provides a single cloud-based platform for your affiliates to use, so you can distribute apps globally and maintain consistent branding and messaging.
To create a local version of the ‘core app’ for a product, country affiliates simply log in and adapt it to fit their market - translating the text, accounting for local competitors and pricing differences etc. The local version is ‘saved’ and distributed to local key account managers with a few clicks.